Inicio › Cáncer del colon y del recto › Illinois › Chicago
Ensayos clínicos de Cáncer del colon y del recto en Chicago, IL
34 estudios para Cáncer del colon y del recto buscan participantes en centros de Chicago y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
ReclutandoFase 1
- The University of Chicago, Chicago
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
ReclutandoFase 3
- University of Chicago Medical Center /ID# 279365, Chicago
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Reclutando
- Northwestern Memorial Hospital, Chicago
Family Communications After Genetic Testing
ReclutandoSe aceptan voluntarios sanos
- Advocate Illinois Masonic Medical Center, Chicago
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
ReclutandoFase 2
- University of Illinois, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- y 1 más
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
ReclutandoFase 1
- Exelixis Clinical Site #26, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
ReclutandoFase 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 3
- Illinois Cancer Specialists, Chicago
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
ReclutandoFase 2
- University of Chicago Medical Center /ID# 271688, Chicago
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
ReclutandoFase 1
- Research Site, Chicago
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
ReclutandoFase 1
- University of Chicago, Chicago
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
ReclutandoFase 3
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
ReclutandoFase 2/3
- Local Institution - 0433, Chicago
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
ReclutandoFase 1/2
- University of Chicago, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
ReclutandoFase 3
- University of Illinois Cancer Center, Chicago
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
ReclutandoFase 3
- Clinical Study Site, Chicago
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
ReclutandoFase 3
- Insight Research Institute, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Lurie Children's Hospital-Chicago, Chicago
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
ReclutandoFase 2
- Research Site, Chicago
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
ReclutandoFase 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
ReclutandoFase 2
- University of Chicago Medical Center /ID# 274742, Chicago
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
ReclutandoEstudio observacional
- Northwestern University-Comprehensive Transplant Center, Chicago
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
ReclutandoFase 1/2
- The University of Chicago Medical Center - Oncology, Chicago
CT-95 in Advanced Cancers Associated With Mesothelin Expression
ReclutandoFase 1
- Context Investigational Site, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
FITting Non-invasive Tests in Lynch Syndrome Surveillance
ReclutandoEstudio observacional
- The University of Chicago Medical Center, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
ReclutandoFase 1/2
- University of Chicago Medical Center, Chicago
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
ReclutandoEstudio observacional
- John H Stroger Jr Hospital of Cook County, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
ReclutandoFase 1/2
- University of Chicago, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
ReclutandoFase 4
- University of Chicago Medical Center, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
ReclutandoEstudio observacional
- Advocate Illinois Masonic Medical Center, Chicago
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
ReclutandoEstudio observacional
- John H Stroger Jr Hospital of Cook County, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
ReclutandoFase 2
- Northwestern University, Chicago
Más información sobre Cáncer del colon y del recto en MedlinePlus
Ensayos de Cáncer del colon y del recto en otras ciudades
- Houston, TX102 estudios
- New York City, NY78 estudios
- Nashville, TN69 estudios
- Boston, MA63 estudios
- Los Angeles, CA59 estudios
- Arlington, VA52 estudios
- St. Louis, MO50 estudios
- San Antonio, TX46 estudios
- Philadelphia, PA44 estudios
- Grand Rapids, MI40 estudios
- Baldwin Park, CA37 estudios
- Tampa, FL34 estudios
Otros estudios en Chicago
- Cáncer de pulmón de células no pequeñas61 estudios
- Cáncer de seno59 estudios
- Cáncer (todos los tipos)51 estudios
- Cáncer metastásico45 estudios
- Cáncer de próstata45 estudios
- Cáncer de pulmón41 estudios
- Obesidad41 estudios
- Cáncer de ovario36 estudios
- Accidente cerebrovascular34 estudios
- Fallo cardíaco31 estudios
- Sobrepeso29 estudios
- Carcinoma de células escamosas de cabeza y cuello26 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.